OptiShot™
Atrial Fibrillation (Pulmonary Vein Isolation)
InvestigationalActive
Key Facts
Indication
Atrial Fibrillation (Pulmonary Vein Isolation)
Phase
Investigational
Status
Active
Company
About CardioFocus
CardioFocus is a private medical device company specializing in pulsed field ablation systems for the treatment of atrial fibrillation. Its core strategy is the integrated co-engineering of catheters and generators, focusing on waveform science and contact mechanics to achieve precise lesion formation. The company's pipeline features two investigational devices: the QuickShot™ Nav focal catheter and the OptiShot™ balloon catheter, both aimed at improving procedural efficiency and outcomes in electrophysiology. CardioFocus operates in the rapidly expanding cardiac ablation market, competing against established players with a science-led, system-level approach.
View full company profileTherapeutic Areas
Other Atrial Fibrillation (Pulmonary Vein Isolation) Drugs
| Drug | Company | Phase |
|---|---|---|
| nPulse Cardiac Catheter System (nsPFA 360° Catheter) | Pulse Biosciences | Feasibility Study |